| UniProt ID | CATL1_HUMAN | |
|---|---|---|
| UniProt AC | P07711 | |
| Protein Name | Cathepsin L1 | |
| Gene Name | CTSL | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 333 | |
| Subcellular Localization | Lysosome. | |
| Protein Description | Important for the overall degradation of proteins in lysosomes.. | |
| Protein Sequence | MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 104 | Ubiquitination | NRKPRKGKVFQEPLF CCCCCCCCCCCCCCC | 42.80 | 21906983 | |
| 104 | Sumoylation | NRKPRKGKVFQEPLF CCCCCCCCCCCCCCC | 42.80 | - | |
| 104 | Sumoylation | NRKPRKGKVFQEPLF CCCCCCCCCCCCCCC | 42.80 | - | |
| 123 | Ubiquitination | RSVDWREKGYVTPVK CCCCHHHHCCEECCC | 47.14 | - | |
| 127 | Phosphorylation | WREKGYVTPVKNQGQ HHHHCCEECCCCCCC | 17.55 | 29396449 | |
| 142 | Phosphorylation | CGSCWAFSATGALEG CCCCEEEECCCCCCC | 19.71 | 22210691 | |
| 216 | Ubiquitination | ESCKYNPKYSVANDT HHHCCCCCCCCCCCC | 46.66 | 21906983 | |
| 218 | O-linked_Glycosylation | CKYNPKYSVANDTGF HCCCCCCCCCCCCCC | 22.37 | 30059200 | |
| 221 | N-linked_Glycosylation | NPKYSVANDTGFVDI CCCCCCCCCCCCCCC | 45.26 | 2275556 | |
| 221 | N-linked_Glycosylation | NPKYSVANDTGFVDI CCCCCCCCCCCCCCC | 45.26 | 2275556 | |
| 223 | Phosphorylation | KYSVANDTGFVDIPK CCCCCCCCCCCCCCH | 32.12 | - | |
| 230 | Ubiquitination | TGFVDIPKQEKALMK CCCCCCCHHHHHHHH | 72.00 | - | |
| 271 | Phosphorylation | YFEPDCSSEDMDHGV EECCCCCCCCCCCCE | 43.90 | 29457462 | |
| 295 | Phosphorylation | TESDNNKYWLVKNSW CCCCCCEEEEEECCC | 13.19 | - | |
| 301 | Phosphorylation | KYWLVKNSWGEEWGM EEEEEECCCCCCCCC | 30.64 | 28509920 | |
| 311 | Phosphorylation | EEWGMGGYVKMAKDR CCCCCHHHHHCCCCC | 7.38 | 28509920 | |
| 322 | S-nitrosylation | AKDRRNHCGIASAAS CCCCCCCCCCCCCCC | 4.88 | 2212679 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CATL1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CATL1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CATL1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RXRA_HUMAN | RXRA | physical | 9837884 | |
| BAG6_HUMAN | BAG6 | physical | 21900206 | |
| EED_HUMAN | EED | physical | 21900206 | |
| RELB_HUMAN | RELB | physical | 21988832 | |
| SGTA_HUMAN | SGTA | physical | 25416956 | |
| CLH2_HUMAN | CLTCL1 | physical | 26186194 | |
| CATH_HUMAN | CTSH | physical | 26186194 | |
| GRDN_HUMAN | CCDC88A | physical | 26186194 | |
| 6PGD_HUMAN | PGD | physical | 26344197 | |
| GRDN_HUMAN | CCDC88A | physical | 28514442 | |
| CLH2_HUMAN | CLTCL1 | physical | 28514442 | |
| CATH_HUMAN | CTSH | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-221, AND MASSSPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-221, AND MASSSPECTROMETRY. | |
| "Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-221. | |